نستخدم ملفات تعريف الارتباط لقياس زيارات الموقع وتحسينه. لا يُفعَّل أي ملف غير ضروري قبل موافقتك. تفاصيل الخصوصية
SIX Swiss Exchange
Figures as of 2026-09-11 07:23
Passed the screens we ran
This is an automated read of published screens, not a fatwa. We name what we ran; whatever we did not run stays outside the read.
Verify the seal before the move →68 / 100 · Compliant, close to the limits
We ran 3 of 5 screens; the score is 68 out of 100 (C).
| Business activity (sector and industry) | No excluded activity in its sector or industry | Passed |
| Interest-bearing debt to market cap | 19.3%, limit 30.0% | Passed |
| Cash and interest-bearing securities to market cap | 3.0%, limit 30.0% | Passed |
| Non-permissible income to revenue | limit 5.0% | Not run: the source does not provide its data |
| Receivables to market cap | Not run: the source does not provide its data |
We do not compute a purification share yet: the source does not break out non-permissible income, and we say so rather than estimate a figure.
Figures as of 2026-09-11 07:23
Solid fundamentals
Figures as of 2026-09-11
An automated quality screen on published figures, not a buy or sell recommendation. Every threshold is stated, every reason is named with its figure and its date, and the decision stays yours.
The same four tools that read the daily report's markets, applied to this stock's completed bars.
Slight lean up · 1 vote from the voting tools
| Cycles | not run daily on this exchange | |
| Historical analog | no reading | |
| Seasonal pattern | year-to-pattern correlation 0.05 | no lean today |
| Momentum | 3-, 6- and 12-month agreement | leans up |
stormy volatility · mid-way in the 20-day range · above the 200-day average for 271 sessions
Completed bars through 2026-09-07 · 6361 bars
An automated read describing what happened in the price series — not a recommendation to buy or sell.
Passed the screens we ran
Novartis AG: 68 / 100 · Compliant, close to the limits. The score out of 100 measures how far the debt and cash ratios sit from their stated limits; the five screens are broken down on this page.
We publish no fair-value figure for Novartis AG. What we publish is a fundamental screen with disclosed thresholds; its current result: Solid fundamentals (Figures as of 2026-09-11). The decision stays yours.
Novartis AG is listed on SIX Swiss Exchange under the symbol NOVN.
This page is open to everyone. Inside the subscription this stock also carries its composite score and its parts, valuation ratios, its share of its sector, a read of its financial statements, a ten-year projection with stated assumptions, and following it from your desk. None of them is a buy or sell recommendation.
